## What does this mean for patients who are currently using Ozempic (Semaglutide) or considering starting the medication
In adults with obesity or overweight who have not achieved adequate results from lifestyle changes (like a reduced-calorie diet and increased physical activity) alone, the American Gastroenterological Association (AGA) recommends adding medication to the lifestyle changes rather than continuing with lifestyle modifications alone
Covering weight loss medications will be a significant expenditure for payers on the pharmacy benefit but could potentially result in long-term savings. Arguments against coverage aside from the steep cost include the lack of historical data on efficacy and reports of gastrointestinal disturbances such as constipation, diarrhea, nausea, vomiting and severe abdominal pain
noise is top priority when you believe youve found a long term theme to stick to
Who Should Not Start This Stack Because CJC-1295 Ipamorelin stimulates growth hormone, patients with active malignancy, a personal history of certain cancers, pregnancy, breastfeeding, uncontrolled diabetes, or significant pituitary disease are generally not candidates
This product has also shown strong market growth.
